
PreemptiveAI is building the foundation model that maps human physiology/pathology and predicts health outcomes in real-time via biomedical signals from smartphones and wearable devices.

PreemptiveAI is building the foundation model that maps human physiology/pathology and predicts health outcomes in real-time via biomedical signals from smartphones and wearable devices.
Sector: Biotechnology / Health AI
Product: Foundation medical model that predicts health outcomes from smartphone and wearable biomedical signals
Headquarters: Seattle, Washington
Founders: Jamien McCullum; Matt Whitehill; Leon Gatys
Recent funding: Seed round (Mar 2024), reported ~$6.4M
| Company |
|---|
Real-time prediction of health outcomes using biomedical signals from consumer devices.
Biotechnology Research
$6.4M
Other reported investors include Precursor Ventures and Inspired Capital